Jean J. Zhao, PhD

Associate Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

Associate Professor, Cancer Biology, Dana-Farber Cancer Institute

Contact Info

Jean Zhao
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA, 02215
Mailstop: Smith 1058B
Phone: 617-632-2932
Fax: 617-632-3709
jean_zhao@dfci.harvard.edu

Assistant

Erin Barber
Administrative Assistant
Cancer Biology
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Phone: 617-632-5744
Fax: 617-582-7737
Erin_Barber@DFCI.HARVARD.EDU

DF/HCC Program Affiliation

Prostate Cancer
Breast Cancer

Research Abstract

We are interested in how kinases in general, and phosphatidylinositol 3-kinases (PI3K) in particular, control malignant transformation. We have developed a number of experimental systems, including knockout and transgeneic mouse models, synthetic human tumors, and kinome-wide libraries of gain/loss-of-function kinases to understand how kinases work, in order to harness their potential as targets for cancer therapies.

Publications

View All Publications

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Jean J. Zhao, PhD Associate Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School Associate Professor, Cancer Biology, Dana-Farber Cancer Institute Contact Info Jean Zhao Dana-Farber Cancer Institute 450 Brookline Avenue Boston, MA, 02215 Mailstop: Smith 1058B Phone: 617-632-2932 Fax: 617-632-3709 jean_zhao@dfci.harvard.edu Assistant Erin Barber Administrative Assistant Cancer Biology Dana-Farber Cancer Institute 44 Binney Street Boston, MA, 02115 Phone: 617-632-5744 Fax: 617-582-7737 Erin_Barber@DFCI.HARVARD.EDU DF/HCC Program Affiliation Prostate Cancer Breast Cancer Research Abstract We are interested in how kinases in general, and phosphatidylinositol 3-kinases (PI3K) in particular, control malignant transformation. We have developed a number of experimental systems, including knockout and transgeneic mouse models, synthetic human tumors, and kinome-wide libraries of gain/loss-of-function kinases to understand how kinases work, in order to harness their potential as targets for cancer therapies. Publications View All Publications
Site Map Site Feedback Web Privacy Policy